Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP‐AF Long‐term General Registry
European Journal of Clinical Investigation2021Vol. 52(4), pp. e13709–e13709
Citations Over Time
Alejandro Pérez Cabeza, José Miguel Rivera‐Caravaca, Inmaculada Roldán‐Rabadán, Javier García Seara, Vicente Bertomeu‐González, Mariano Leal Hernández, Amaya García-Fernández, Luís Tercedor, M. Ayarra, Marianela Ciudad, S. Castaño, Ana M. Maestre, Manuel Anguita, Ignacio García Bolao, Francisco Marı́n
Abstract
In this contemporary cohort of AF patients, OAC therapy was associated with better clinical outcomes at 1 year and positive NNTnet. OAC use slightly increased during the follow-up, with low discontinuation rates and higher prescription of DOACs.
Related Papers
- → Experimental antithrombotic effect of potatoes harvested in the autumn(2012)5 cited
- Antithrombotic therapy in atrial fibrillation.(1996)
- → Antithrombotic Therapy: Focus on the Elderly(2017)1 cited
- Types Research of Discontinuation of a Crime(2007)